EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Self-Reported Weight Loss During the Use of a Lifestyle Therapy Prescription Digital Therapeutic in Adults with Obesity and Self-Reported Cardiovascular Risk Factors or Cardiovascular Disease

Kathleen Wiencke, Romina Zimmermann, Annika Gentz, Sara Clever, Saemundur J. Oddsson, Till Hasenberg, David O. Arnar, Andrew Grannell

Obesities · 11.07.2026 · 6 (4) · 51

DOI: 10.3390/obesities6040051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesities, online erschienen am 11.07.2026. Verfasst von Kathleen Wiencke und 7 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a risk factor in cardiovascular disease (CVD), and scalable treatment approaches are needed in routine care. The aim of this retrospective observational study was to investigate self-reported weight change during the use of a prescription digital therapy for multimodal lifestyle therapy for obesity. Adults with obesity and self-reported CVD risk factors (n = 4314) or self-reported established CVD (n = 1418) prescribed zanadio for up to 12 months were included. The primary outcome was percentage change in self-reported body weight over time. Clinically meaningful weight loss (≥5%) was observed in patients on continued prescriptions, with greater weight loss observed in patients with prolonged program exposure. The results were directionally consistent across analyses that used a randomly missing approach and a sensitivity analysis with the last observation forward, although estimates varied in magnitude. Interpretation of this data in a real-world setting is limited by self-reported weight and comorbidity data, attrition which is typical for weight loss programs in the reality of care, and uncertainty about the mechanism of missing data. These results suggest that zanadio may support clinically meaningful self-reported weight loss in patients continuing treatment, but further studies linking clinical data and with longer follow-up are needed.

Zitieren

APA

Wiencke, K., Zimmermann, R., Gentz, A., Clever, S., Oddsson, S. J., Hasenberg, T., Arnar, D. O., & Grannell, A. (2026). Real-World Self-Reported Weight Loss During the Use of a Lifestyle Therapy Prescription Digital Therapeutic in Adults with Obesity and Self-Reported Cardiovascular Risk Factors or Cardiovascular Disease. Obesities, 6(4), 51. https://doi.org/10.3390/obesities6040051

Vancouver

Wiencke K, Zimmermann R, Gentz A, Clever S, Oddsson SJ, Hasenberg T, et al. Real-World Self-Reported Weight Loss During the Use of a Lifestyle Therapy Prescription Digital Therapeutic in Adults with Obesity and Self-Reported Cardiovascular Risk Factors or Cardiovascular Disease. Obesities. 2026;6(4):51. doi:10.3390/obesities6040051

BibTeX
@article{Wiencke2026,
  author = {Wiencke, Kathleen and Zimmermann, Romina and Gentz, Annika and Clever, Sara and Oddsson, Saemundur J. and Hasenberg, Till and Arnar, David O. and Grannell, Andrew},
  title = {Real-World Self-Reported Weight Loss During the Use of a Lifestyle Therapy Prescription Digital Therapeutic in Adults with Obesity and Self-Reported Cardiovascular Risk Factors or Cardiovascular Disease},
  journal = {Obesities},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {51},
  doi = {10.3390/obesities6040051}
}
Kostenlos starten →